期刊文献+

耐力训练及左卡尼汀对缺血修饰性清蛋白水平的影响

下载PDF
导出
摘要 目的通过观察血浆缺血修饰性清蛋白(IMA)水平的动态变化,研究耐力训练及服用左卡尼汀对IMA水平的影响。方法选择90名新入伍战士,随机分为口服左卡尼汀组(实验组)及对照组,采用双抗体夹心ELISA法分别检测2组在5km越野运动前、越野后即刻及4h的IMA水平,并进行统计学分析。结果实验组IMA水平与对照组相比,运动前、运动后即刻及运动后4h均低于对照组且差异有统计学意义(P<0.05);运动后4hIMA水平与运动前、运动后即刻相比,对照组和实验组都有所升高(P<0.05),而运动后即刻与运动前相比,实验组与对照组差异均无统计学意义(P>0.05)。结论IMA对评估耐力训练导致的心肌缺血有一定意义,左卡尼汀对心肌有保护作用。
出处 《临床检验杂志》 CAS CSCD 北大核心 2009年第5期366-367,共2页 Chinese Journal of Clinical Laboratory Science
  • 相关文献

参考文献6

  • 1Bar-Or D, Winkler J V, Vanbenthuysen K,et al. Reduced albumincobalt binding with transient myocardial ischemia after elective percutaneous t ran luminal coronary angioplasty : a preliminary comparison to creatine kinase-MB , myoglobin , and troponin I[ J ]. Am Heart J,2001,141 (6) :985-991.
  • 2王继贵,陈新瑞,胡敏.缺血修饰清蛋白测定及评价[J].临床检验杂志,2005,23(3):177-179. 被引量:7
  • 3王亚平,姜宇海,吴雪江.缺血修饰清蛋白对急性冠脉综合征的诊断价值[J].临床检验杂志,2008,26(6):456-456. 被引量:5
  • 4Apple F S,Quist H E,Otto A P,et al. Release characteristics of cardiac biomarkers and ischemia modified albumin asmeas ured by the albumin cobalt binding test after a marathon race [ J ]. Clin Chem, 2002,48 : 1097 -1100.
  • 5Bar-Or D, Lau E, Winkler J V. A novel assay for cobalt-albumin binding and it s potential as a marker for myocardial ischemia-a preliminary report [ J ]. J Emerg Med ,2000,19 (4) : 311-315.
  • 6季先友.左卡尼汀治疗缺血性心肌病心衰的疗效观察[J].齐齐哈尔医学院学报,2007,28(2):132-134. 被引量:10

二级参考文献18

  • 1Montagnana M, Lippi G, Guidi G C. New perspectives in the diagnostic approach to acute coronary syndrome [ J ]. Reccnti Prog Med, 2005,96(4) :171.
  • 2Bar-Or D, Lau E, Rao N, et al. Reduction in cobalt binding capacity of human albumin with myocardial ischemica [ J ]. Ann Emerg Med, 1999,34 (4sUppl) : s56.
  • 3Peacock F,Morris D L,Anwaruddin S,et al. Meta -analysis of ischemia modified albumin to rule out acute coronary syndromes in the emergency department[J]. Am Heart J,2006,152(2) :253.
  • 4Bar-Or D, Lau E, Rao N, et al. Reduction in the cobalt binding capacity of human albumin with myocardial ischemia [ J ]. Ann Emerg Med, 1999,34 (4 Suppl): S56.
  • 5Sinha M K, Roy D, Gaze D C, et al. Role of" ischemia modified albumin", a new biochemical marker of myocardial ischaemia, in the early diagnosis of acute coronary syndromes[ J]. EMJ ,2004,21 ( 1 ) :29-34.
  • 6Christenson R H, Duh S H, Sanhai W R, et al. Characteristic of an albumin cobalt binding test for assessment of acute coronary syndrome patients: a multicenter study [ J ]. Clin Chem ,2001,47 ( 3 ) :464-470.
  • 7Jesse A, Fred A. New blood tests for detecting heart disease[J]. Circulation, 2004,109 ( 3 ): e12-e14.
  • 8Bar-Or D, Lau E, and Winkler J V. A novel assay for cobaltalbumin binding and its potential as a marker for myocardial ischemia-a preliminary report [ J]. J Emerg Med, 2000, 19(4) :311-315.
  • 9Bhagavan N V, Lai E M, Rios P A, et al. Evaluation of human serum albumin cobalt binding assay for the assessment of myocardial ischemia and myocardial infarction[J]. Clin Chem,2003,49(4) :581-585.
  • 10Bar-Or D, Winkler J V, Vanbenthuysen K, et al. Reduced albumin-cobalt binding with transient myocardial ischemia after elective percutaneous transluminal coronary angioplasty: A preliminary comparison to creatine kinaseMB, myoglobin, and troponin Ⅰ [ J ]. Am Heart J,2001,141(6) :985-991.

共引文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部